Capsida Company

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Industry: Early Drug Development
Headquarters: Newbury Park, California, United States
Founded Date: 2019-01-01
Employees Number: 51-100
Investors Number: 3
Total Funding: 140000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2023-02-23
Last Funding Type: Corporate Round

Visit Website
Register and Claim Ownership